Richard Levy
Fortune : 14 M $ au 30/06/2026
Fortune : 14 M $ au 30/06/2026
Richard S.
Levy is currently a Non-Executive Director at Gliknik, Inc. since 2014.
Independent Director at Kiniksa Pharmaceuticals Ltd. since 2019.
Independent Director at Madrigal Pharmaceuticals, Inc. since 2016.
Independent Director at Kodiak Sciences, Inc. since 2018.
Independent Director at Protara Therapeutics, Inc. since 2019.
Independent Director at Kiniksa Pharmaceuticals International Plc since 2024.
Formerly an Independent Director at Aquinox Pharmaceuticals, Inc. from 2017 to 2019.
Independent Director at Constellation Pharmaceuticals, Inc. from 2020 to 2021.
Director at ArTara Subsidiary, Inc. from 2019 to 2020.
Vice President-Biologic Therapies at Celgene Corp.
from 2002 to 2003.
Chief Drug Development & Medical Officer, EVP at Incyte Corp.
from 2009 to 2016.
Vice President-Medical & Commercial Strategy at DuPont Pharmaceuticals Co. from 1997 to 2002.
Principal at Sandoz Corp.
in 1997.
Assistant Professor at David Geffen School of Medicine.
Assistant Professor at the University of California Los Angeles Graduate School.
Education includes undergraduate degree from Brown University, doctorate degrees from the University of Pennsylvania and Perelman School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 22 469 ( 0,1 % ) | 12 M $ | 30/06/2026 | |
0,05 % | 29/05/2026 | 21 956 ( 0,05 % ) | 1 M $ | 30/06/2026 |
| 15/06/2026 | 51 000 ( 0,09 % ) | 194 820 $ | 30/06/2026 | |
| 30/06/2026 | 1 000 ( 0 % ) | 38 960 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/08/2016 |
| KODIAK SCIENCES INC. | Directeur/Membre du Conseil | 18/07/2018 |
| PROTARA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2020 |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Directeur/Membre du Conseil | 04/03/2019 |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biotechnology drugs for autoimmune diseases and cancer | Directeur/Membre du Conseil | 19/02/2014 |
| Sociétés | Poste | Fin |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/06/2021 |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2020 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Directeur/Membre du Conseil | 08/08/2019 |
| INCYTE CORPORATION | Directeur Technique/Scientifique/R&D | 30/04/2016 |
| ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biotechnology drugs for autoimmune diseases and cancer | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Sandoz Corp.
Sandoz Corp. Pharmaceuticals: MajorHealth Technology Developes, produces and markets medicines | Health Technology |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of California Los Angeles Graduate School
University of California Los Angeles Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kodiak Sciences, Inc.
Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national